Genetic Susceptibility and Environmental Triggers

Rheumatic autoimmune diseases are complex traits: no single gene causes them, but many genetic variants — led by the HLA region — raise susceptibility, and disease typically appears only when predisposed individuals meet environmental triggers. This gene-environment interplay explains familial clustering, incomplete twin concordance, and the long preclinical phase of autoimmunity.

Definition

Genetic susceptibility to rheumatic disease is the inherited component of risk — chiefly HLA alleles plus many small-effect non-HLA variants — that, in combination with environmental triggers, raises the probability of developing autoimmune disease.

Scope

The topic covers the genetic architecture of rheumatic susceptibility, the central role of the HLA/MHC region, the contribution of many non-HLA variants, and the environmental exposures thought to trigger disease in susceptible people. It treats susceptibility as a population-level mechanism, not as individual genetic risk prediction.

Core questions

• Why is the HLA region the strongest genetic risk locus for many rheumatic diseases?
• How do many small-effect variants combine into a complex-trait architecture?
• Which environmental exposures act as triggers in susceptible individuals?
• How do genes and environment interact to break tolerance?

Key concepts

• Complex (polygenic) trait architecture
• HLA/MHC association and the shared epitope
• Non-HLA susceptibility loci
• Genome-wide association studies
• Gene-environment interaction
• Environmental triggers (smoking, infection)
• Heritability and twin concordance

Mechanisms

Susceptibility to rheumatic disease is distributed across many loci, with the HLA/MHC region carrying the largest effect because particular class II alleles shape which self-peptides are presented to T cells; the structure of this region was mapped in detail by de Bakker et al. (2006), and genome-wide association studies such as the Wellcome Trust Case Control Consortium (2007) identified numerous additional risk variants of individually modest effect. These variants set a threshold of immune dysregulation that environmental exposures can cross. In rheumatoid arthritis, the interaction of HLA shared-epitope alleles with cigarette smoking is a well-described example of gene-environment interaction promoting anti-citrullinated protein immunity (McInnes & Schett, 2011); in lupus, both genetic and environmental factors converge on disordered tolerance (Tsokos, 2011).

Clinical relevance

Knowing that rheumatic diseases are complex gene-environment traits explains why they cluster in families without following simple inheritance and why modifiable exposures matter. This entry describes population-level mechanisms of susceptibility; it is not a basis for individual genetic testing or risk counselling.

Epidemiology

Heritability estimates from twin and family studies indicate a substantial but incomplete genetic contribution to diseases such as rheumatoid arthritis and lupus, with concordance higher in monozygotic than dizygotic twins, underscoring the role of environment alongside genes as summarised in the cited literature.

History

HLA associations with rheumatic diseases, including the link between class II alleles and rheumatoid arthritis captured in the shared-epitope hypothesis, were established from the 1970s onward. The arrival of genome-wide association studies in the 2000s, exemplified by the Wellcome Trust Case Control Consortium, revealed the polygenic architecture of these diseases and reframed susceptibility as the sum of many variants interacting with environmental triggers.

Debates

How much of disease risk can genetics explain?

Genome-wide studies identify many loci yet account for only part of estimated heritability, leaving open how much is due to undiscovered variants, gene-environment interaction, or epigenetic factors.

Key figures

• Iain McInnes
• Georg Schett
• George Tsokos
• Paul de Bakker

Seminal works

• wtccc-2007
• de-bakker-2006

Frequently asked questions

If a parent has an autoimmune rheumatic disease, will the child inherit it?

Not in a simple way. These are complex polygenic traits, so a family history raises risk modestly but does not determine disease; most people who carry susceptibility variants never develop the condition because environmental triggers are also required.

Why is the HLA region so important?

HLA class II molecules determine which self-peptides are presented to T cells, so particular alleles can favour activation of autoreactive T cells, making the HLA/MHC region the strongest genetic risk locus for many rheumatic diseases.